168 related articles for article (PubMed ID: 27644645)
41. A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.
Dunwell T; Hesson L; Rauch TA; Wang L; Clark RE; Dallol A; Gentle D; Catchpoole D; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Feb; 9():44. PubMed ID: 20184741
[TBL] [Abstract][Full Text] [Related]
42. Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.
Schafer E; Irizarry R; Negi S; McIntyre E; Small D; Figueroa ME; Melnick A; Brown P
Blood; 2010 Jun; 115(23):4798-809. PubMed ID: 20215641
[TBL] [Abstract][Full Text] [Related]
43. DNA methylcytosine dioxygenase ten-eleven translocation 2 enhances lipopolysaccharide-induced cytokine expression in human dental pulp cells by regulating MyD88 hydroxymethylation.
Wang X; Feng Z; Li Q; Yi B; Xu Q
Cell Tissue Res; 2018 Aug; 373(2):477-485. PubMed ID: 29654353
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.
Corn PG; Kuerbitz SJ; van Noesel MM; Esteller M; Compitello N; Baylin SB; Herman JG
Cancer Res; 1999 Jul; 59(14):3352-6. PubMed ID: 10416592
[TBL] [Abstract][Full Text] [Related]
45. Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms.
Scopim-Ribeiro R; Machado-Neto JA; de Melo Campos P; Niemann FS; Lorand-Metze I; Costa FF; Olalla Saad ST; Traina F
Diagn Pathol; 2016 Mar; 11():28. PubMed ID: 26984174
[TBL] [Abstract][Full Text] [Related]
46. The DNA methylome of pediatric acute lymphoblastic leukemia.
Davidsson J; Lilljebjörn H; Andersson A; Veerla S; Heldrup J; Behrendtz M; Fioretos T; Johansson B
Hum Mol Genet; 2009 Nov; 18(21):4054-65. PubMed ID: 19679565
[TBL] [Abstract][Full Text] [Related]
47. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
48. TET2 mutations in childhood leukemia.
Langemeijer SM; Jansen JH; Hooijer J; van Hoogen P; Stevens-Linders E; Massop M; Waanders E; van Reijmersdal SV; Stevens-Kroef MJ; Zwaan CM; van den Heuvel-Eibrink MM; Sonneveld E; Hoogerbrugge PM; van Kessel AG; Kuiper RP
Leukemia; 2011 Jan; 25(1):189-92. PubMed ID: 21042320
[No Abstract] [Full Text] [Related]
49. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
[TBL] [Abstract][Full Text] [Related]
50. DNA methylation analysis of bone marrow cells at diagnosis of acute lymphoblastic leukemia and at remission.
Nordlund J; Milani L; Lundmark A; Lönnerholm G; Syvänen AC
PLoS One; 2012; 7(4):e34513. PubMed ID: 22493696
[TBL] [Abstract][Full Text] [Related]
51. Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region.
Ortmann CA; Burchert A; Hölzle K; Nitsche A; Wittig B; Neubauer A; Schmidt M
Nucleic Acids Res; 2005; 33(21):6895-905. PubMed ID: 16396836
[TBL] [Abstract][Full Text] [Related]
52. Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter.
San José-Enériz E; Agirre X; Román-Gómez J; Cordeu L; Garate L; Jiménez-Velasco A; Vázquez I; Calasanz MJ; Heiniger A; Torres A; Prósper F
Br J Haematol; 2006 Jul; 134(2):137-44. PubMed ID: 16846474
[TBL] [Abstract][Full Text] [Related]
53. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
54. Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis.
Wang CX; Wang X; Liu HB; Zhou ZH
Asian Pac J Cancer Prev; 2014; 15(1):355-62. PubMed ID: 24528056
[TBL] [Abstract][Full Text] [Related]
55. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
56. Ten-eleven-translocation 2 (TET2) is downregulated in myelodysplastic syndromes.
Scopim-Ribeiro R; Machado-Neto JA; Campos Pde M; Silva CA; Favaro P; Lorand-Metze I; Costa FF; Saad ST; Traina F
Eur J Haematol; 2015 May; 94(5):413-8. PubMed ID: 25200248
[TBL] [Abstract][Full Text] [Related]
57. TET2-interacting long noncoding RNA promotes active DNA demethylation of the MMP-9 promoter in diabetic wound healing.
Zhou L; Ren M; Zeng T; Wang W; Wang X; Hu M; Su S; Sun K; Wang C; Liu J; Yang C; Yan L
Cell Death Dis; 2019 Oct; 10(11):813. PubMed ID: 31653825
[TBL] [Abstract][Full Text] [Related]
58. TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia.
Bensberg M; Rundquist O; Selimović A; Lagerwall C; Benson M; Gustafsson M; Vogt H; Lentini A; Nestor CE
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34413196
[TBL] [Abstract][Full Text] [Related]
59. [Hypermethylation of CpG island in promoter region of MEIS1 gene and its expression in HOX11(+) acute T lymphoblastic leukemia].
Jia JS; Spicuglia S
Zhonghua Yi Xue Za Zhi; 2013 Dec; 93(48):3835-40. PubMed ID: 24548444
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]